Bolt Biotherapeutics (STU:6LP) ROE % Adjusted to Book Value : -229.15% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bolt Biotherapeutics ROE % Adjusted to Book Value?

Bolt Biotherapeutics's ROE % for the quarter that ended in Sep. 2024 was -75.62%. Bolt Biotherapeutics's PB Ratio for the quarter that ended in Sep. 2024 was 0.33. Bolt Biotherapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -229.15%.

Bolt Biotherapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Bolt Biotherapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bolt Biotherapeutics ROE % Adjusted to Book Value Chart

Bolt Biotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-198.74

-155.00

-136.69

Bolt Biotherapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-161.60	-167.86	-88.76	-271.85	-229.15

Competitive Comparison of Bolt Biotherapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Bolt Biotherapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bolt Biotherapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bolt Biotherapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bolt Biotherapeutics's ROE % Adjusted to Book Value falls into.

Bolt Biotherapeutics ROE % Adjusted to Book Value Calculation

Bolt Biotherapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-47.84%	/	0.35
	=	-136.69%

Bolt Biotherapeutics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-75.62%	/	0.33
	=	-229.15%

Bolt Biotherapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Bolt Biotherapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Bolt Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bolt Biotherapeutics Inc (STU:6LP) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

BOLT:USA

Address

900 Chesapeake Drive, Redwood, CA, USA, 94063

Website

https://www.boltbio.com

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Bolt Biotherapeutics Headlines

No Headlines